1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
65071D9D6B4BC907985256ECF006E8822
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/safeguarding-against-counterfeit-products-developing-the-pharmaceutical-brand-security-function?opendocument
18
19opendocument
203.80.4.76
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing Marketing Management Deploying Marketing Programs Brand Management

Safeguarding Against Counterfeit Products: Developing the Pharmaceutical Brand Security Function

DB Image

ID: 4694


Features:

Metrics, Graphics


Pages/Slides: 25


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Study Overview

This survey-based benchmarking exchange was designed to understand how brand security functionss are organized and resourced to effectively safeguard against counterfeit products across business units and geographies. Pharmaceutical companies can benefit from this 25-slide presentation on the most commonly utilized brand security functions so that they can establish efficiently operated safeguard operations against counterfeit products.

Key Topics

  • Introduction and Key Findings
  • Organizational Structure and Oversight of the Function
  • Staff and Resource Investment in the Function
  • Scope of Services and Activities Conducted by the Function
  • Top Lessons Learned

Sample Best Practices
  • The great majority of benchmark partners have organized their brand security functions in a centralized manner verses a form of hybrid model of organization. *80% of the benchmark class organizes responsibility for the brand security function in a centralized manner.
  • The benchmark average for number of full-time equivalents (FTEs) to support the brand security function is 5. *Only two of the 10 surveyed companies report significantly larger staff resources allocated to brand security Functions.
  • The following monitoring and surveillance activities employed by the brand security function have been identified by the benchmark as key components: Supply chain inspections, product testing, auditing wholesale product transactions, monitoring internet activity, and auditing product sales.
    * The benchmark average for the number of identified key monitoring and surveillance activities employed by brand security functions is three. Only three surveyed brand security functions manage all of the monitoring and surveillance activities.

Methodology
This document is the result of a Best Practices, LLC project for a pharmaceutical Business Excellence Board client. It is based on the survey responses of 10 leading benchmark partners in the
pharmaceutical industry.

Industries Profiled:
Medical Device; Pharmaceutical; Health Care; Biotech; Chemical


Companies Profiled:
3M Pharmaceuticals; Sanofi-aventis; Abbott Laboratories; Merck; Ortho Biotech; Pfizer; Procter & Gamble Pharma; Solvay America

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.